WallStreetZenWallStreetZen

NASDAQ: ALT
Altimmune Inc Stock Ownership - Who owns Altimmune?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Altimmune Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Vipin K. GargPresident and CEO2024-02-028,376$9.32
$78.06kSell
Matthew Scott HarrisChief Medical Officer2024-02-022,332$9.32
$21.73kSell
M. Scot RobertsChief Scientific Officer2024-02-022,330$9.32
$21.72kSell
M. Scot RobertsChief Scientific Officer2024-02-011,801$9.88
$17.79kSell
Matthew Scott HarrisChief Medical Officer2024-02-011,801$9.88
$17.79kSell
Vipin K. GargPresident and CEO2024-02-017,313$9.88
$72.25kSell
Raymond M. JordtChief Business Officer2024-01-315,030$2.69
$13.53kBuy
Matthew Scott HarrisChief Medical Officer2024-01-313,257$2.69
$8.76kBuy
Richard I. EisenstadtChief Financial Officer2024-01-314,621$2.69
$12.43kBuy
M. Scot RobertsChief Scientific Officer2024-01-315,860$2.69
$15.76kBuy

1 of 3

ALT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALT insiders and whales buy or sell their stock.

ALT Shareholders

What type of owners hold Altimmune Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Prescott Group Capital Management LLC27.98%19,837,273$140.45MInsider
Novartis Bioventures Ltd11.77%8,345,145$59.08MInsider
Mpm Bioventures Iii LLC8.95%6,347,614$44.94MInsider
Luke Evnin8.95%6,347,614$44.94MInsider
Healthcare Ventures Vii LP6.18%4,378,057$31.00MInsider
Ameriprise Financial Inc5.90%4,183,682$29.62MInstitution
Blackrock Inc5.71%4,044,707$28.64MInstitution
Vanguard Group Inc5.04%3,571,972$25.29MInstitution
Venrock Healthcare Capital Partners Iii LP4.94%3,500,000$24.78MInsider
James H. Cavanaugh4.68%3,317,243$23.49MInsider

1 of 3

ALT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALT34.70%65.30%Net SellingNet Selling
PRME32.55%67.45%Net BuyingNet Buying
ANAB41.94%58.06%Net SellingNet Selling
ORIC70.31%29.69%Net SellingNet Selling
CVAC9.83%0.00%
View Top Biotech Stocks

Altimmune Stock Ownership FAQ

Who owns Altimmune?

Altimmune (NASDAQ: ALT) is owned by 47.26% institutional shareholders, 88.92% Altimmune insiders, and 0.00% retail investors. Prescott Group Capital Management LLC is the largest individual Altimmune shareholder, owning 19.84M shares representing 27.98% of the company. Prescott Group Capital Management LLC's Altimmune shares are currently valued at $142.83M.

If you're new to stock investing, here's how to buy Altimmune stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.